Yourgene was acquired by Novacyt in September 2023, in a £16.7m deal.

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for ...

The root causes of most forms of Alzheimer's disease largely remain a mystery. Now, researchers have revealed a new piece of the puzzle.

Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare ...

Announces Exit of DNA Tagging and Security Products and Services Business Segment -- Workforce Reduction of 20% of Headcount Implemented in ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, ...

Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, today announced the launch of IONA® Care+, a fully comprehensive non-invasive prenatal ...

Two new studies represent a big step toward developing innovative molecular therapies capable of disrupting the ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...